Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeHealth

      Health

      InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025
      Health

      InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025

      June 1, 2025
      /R E P E A T — MEDIA ADVISORY – Walking in Support of the 322,000+ people in Canada with Crohn’s or colitis/
      Health

      /R E P E A T — MEDIA ADVISORY – Walking in Support of the 322,000+ people in Canada with Crohn’s or colitis/

      June 1, 2025
      Global tobacco experts issue stark warning that the world is on brink of turning into an ‘ashtray planet’ that will significantly escalate chronic respiratory diseases
      Health

      Global tobacco experts issue stark warning that the world is on brink of turning into an ‘ashtray planet’ that will significantly escalate chronic respiratory diseases

      May 31, 2025
      HER3-DXd shows promising results in the phase II TUXEDO-3 study for patients with limited therapeutic options
      Health

      HER3-DXd shows promising results in the phase II TUXEDO-3 study for patients with limited therapeutic options

      May 31, 2025
      All Charges Dismissed Against Dr. Kingsley R. Chin and His Companies as DOJ Case Concludes
      Health

      All Charges Dismissed Against Dr. Kingsley R. Chin and His Companies as DOJ Case Concludes

      May 31, 2025
      New IMV Study Reveals Key Trends in U.S. Breast Imaging: Procedure Growth, Equipment Plans, and Patient Priorities
      Health

      New IMV Study Reveals Key Trends in U.S. Breast Imaging: Procedure Growth, Equipment Plans, and Patient Priorities

      May 31, 2025
      Biomarkers Market worth US$104.15 billion in 2030 with 10.8% CAGR | MarketsandMarkets™
      Health

      Biomarkers Market worth US$104.15 billion in 2030 with 10.8% CAGR | MarketsandMarkets™

      May 31, 2025
      GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
      Health

      GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

      May 31, 2025
      FARE Announces Support of the American Center for Cures
      Health

      FARE Announces Support of the American Center for Cures

      May 31, 2025
      Alma Unveils Alma IQ at Eighth Global Alma Academy in Dubrovnik
      Health

      Alma Unveils Alma IQ at Eighth Global Alma Academy in Dubrovnik

      May 30, 2025
      « 1 … 51 52 53 54 55 … 256 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026